.jpg--.jpg)
Rome, 22 April (beraking latest news) – SituGel, CareLiver and PharmHack are the names of the three finalist projects of the Alfathon, the first full digital hackathon conceived by Alfasigma to give life to a long-term Open Innovation project. Three challenges launched by the pharmaceutical company to contribute to research and innovation in the sector, over 40 participants and more than 10 European and non-EU countries involved. Among these, the projects of two Italian and one Spanish teams stood out, proposing innovative and valuable solutions in the different areas in which the competition is divided.
Designed by Lluis Pascual Masiá, PhD in Medicines and Health at the University of Navarra and by Irene Santos Martínez and Maria Cholvi Simó, pharmacy students at the University of Valencia, SituGel responds to the need to develop a formulation platform capable of guaranteeing liberation prolongation of the active principle thus maximizing its therapeutic action.
CareLiver, on the other hand, is an App for monitoring, prevention and data collection on liver cirrhosis, born as a support tool for caregivers, patients and doctors. Chosen as the best proposal among those presented in the Challenge that asked for the development of software / hardware for the management of hepatic encephalopathy, it was conceived by Alice Bondi, Luca Cellamare, Luisa Cicolini and Isabella Poles, students of the Politecnico di Milano. Proposed in Challenge no. 3, which aims to bring the pharmacist closer to its customers, PharmHack enables an efficient and automatic interaction between the Patient and the various actors of the local healthcare, including Doctor, Pharmacist and Caregiver. It is a platform conceived by Aldo Pasca Raymondi, Steven Cortinovis, Paolo Liuzzi, Alice Chiappini and Giorgio Invernizzi to completely digitize commercial processes and similarly, in terms of therapeutic adherence, guarantee the management of the treatment plan and the performance agenda in pharmacy, Mmg and Cup.
In addition to the projects that reached the final to compete for the prize of 5,000 euros, there were many other innovative and cutting-edge ideas presented by young talents from all over the world. For this reason, Alfasigma has decided to give life to the Alfathon community, thus allowing all the protagonists of this digital challenge, the opportunity to collaborate together and collect innovation ideas, with a view to Open Innovation that goes beyond the podium. of the competition. “We are happy to have supported this Open Innovation project which saw the participation of young innovators ready to contribute to Alfasigma’s Digital Transformation process – underlines Pier Vincenzo Colli, CEO of Alfasigma -. Indeed, the Alfathon has allowed us to involve many valuable partners and internal and external stakeholders who will accompany us on this path of digital development and growth “.
The evaluation and selection of the finalists was carried out by the Hack Committee composed of: Silvia Maltoni G Factor Golinelli Foundation, Matteo Vignoli Unibo, Bernardo Balboni Unimore, Lorenzo Ridola Sapienza University, Simona Morcellini Deputy Mayor and Councilor for Productive Activities, Tourism and Culture of the Municipality of Pomezia, Carolina Carosio President Fenagifar National Federation of Young Pharmacists, Ivan Gardini President of the EpaC Onlus Association, Matteo Fortini Civic Hacker, Andrea Bonaccorsi University of Pisa, Achille Gallina Toschi Pharmacy Toschi Bologna, Beatrice Albertini PhD Department of Pharmacy and BioTechnology and Nadia Passerini Department of Pharmacy and Biotechnology University of Bologna
A special recognition is addressed to the teams in the local area of Pomezia, where a production plant and a Research and Development center in Pomezia are located. Partner of the StartUpItalia initiative, University of Modena and Reggio Emilia, University of Bologna, Golinelli Foundation, Municipality of Pomezia, NecstLab – Department of Electronics, Information and Bioengineering (Deib) – of the Politecnico di Milano, University of Camerino, Epac onlus point of reference for patients with hepatitis and liver diseases, Junto innovation Hub, and the laboratory of communication science students CommToAction.
The nomination of the Alfathon finalists took place during the first appointment with the Innovation Talks, the Clubhouse room dedicated to technological innovation and health, created by the pharmaceutical company. A periodic appointment in which the main innovative trends in the healthcare sector can be analyzed, but not only, thanks to the contribution of guests who are experts in the sector.
Alfasigma, one of the main players in the Italian pharmaceutical industry, is a company focused on medical prescription specialties, self-medication and nutraceutical products. Founded in 2015 from the merger of the Alfa Wassermann and Sigma-Tau groups – two of the historic Italian pharmaceutical companies – today it is present with branches and distributors in about 90 countries around the world. The company employs over 3,000 employees, of which more than half in Italy are divided into 5 offices: the headquarters of the international division in Bologna and the headquarters of the international division in Milan, while in Pomezia (RM), Alanno (PE) and Sermoneta (LT) are localized the production sites. Bologna and Pomezia also host Research and Development laboratories. In Italy Alfasigma is a leader in the prescription product market where it is present in many primary care therapeutic areas (cardio, ortho-rheuma, gastro, pneumo, vascular, diabetes) as well as marketing self-medication products of great renown, such as Biochetasi, NeoBorocillin, Dicloreum and Yovis. For more information, visit www.alfasigma.com.